Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors

BACKGROUND: Although factor Xa inhibitors have become a popular choice for chronic oral anticoagulation, effective drug reversal remains difficult due to a lack of specific antidote. Currently, 4-factor prothrombin complex concentrate (4F-PCC) is considered the treatment of choice for factor Xa inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Jing, Bukanova, Elena N., Akhtar, Shamsuddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001072/
https://www.ncbi.nlm.nih.gov/pubmed/29942519
http://dx.doi.org/10.1186/s40560-018-0303-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001072/
https://www.ncbi.nlm.nih.gov/pubmed/29942519
http://dx.doi.org/10.1186/s40560-018-0303-y

Ejemplares similares